ArticleBriefings in bioinformatics2024
Prototype-based contrastive substructure identification for molecular property prediction.
Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Energy-Screened Many-Body Expansion for Protein-Ligand Interactions: Examining Convergence for Metalloenzymes Through Seven-Body Interactions.Journal of chemical theory and computation · 2026Article
- ProtoMol: enhancing molecular property prediction via prototype-guided multimodal learning.Briefings in bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Substructure-based representation learning has emerged as a powerful approach to featurize complex attributed graphs, with promising results in molecular property prediction (MPP). However, existing MPP methods mainly rely on manually defined rules to extract substructures. It remains an open challenge to adaptively identify meaningful substructures from numerous molecular graphs to accommodate MPP tasks. To this end, this paper proposes Prototype-based cOntrastive Substructure IdentificaTion (POSIT), a self-supervised framework to autonomously discover substructural prototypes across graphs so as to guide end-to-end molecular fragmentation. During pre-training, POSIT emphasizes two key aspects of substructure identification: firstly, it imposes a soft connectivity constraint to encourage the generation of topologically meaningful substructures; secondly, it aligns resultant substructures with derived prototypes through a prototype-substructure contrastive clustering objective, ensuring attribute-based similarity within clusters. In the fine-tuning stage, a cross-scale attention mechanism is designed to integrate substructure-level information to enhance molecular representations. The effectiveness of the POSIT framework is demonstrated by experimental results from diverse real-world datasets, covering both classification and regression tasks. Moreover, visualization analysis validates the consistency of chemical priors with identified substructures. The source code is publicly available at https://github.com/VRPharmer/POSIT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.